Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A clinical study (Phase III) to assess the Evaluate the Protective Efficacy and Safety of a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT), when compared against placebo in a randomised, double blind manner https://www.kusajili.fr:443/Trial/0xGjhbNA2ES10i6lGzlBGQ%24a-clinical-study-phase-iii-to-assess-the-evaluate-the-protective-efficacy-and-safety-of-a-therapeutic-vaccine-asp0113-in-cytome
I have read and accept the terms of use of the site and the Privacy Policy
Send your message